BridgeMD
New treatment option for Vaping
Official title The Use of tDCS for Vaping Reduction
ClinicalTrials.gov ID: NCT06885606
What this study is testing
- What it's testing
- Project Summary - tDCS for Vaping Reduction Background: While the prevalence of tobacco smoking has plateaued over the last several years, the prevalence of nicotine vaping (e-cigarettes) continues to increase exponentially in Canada. Originally touted as a safe alternative to smoking, e-cigarette use or vaping is now most popular among youth and young adults.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- The participant must meet all of the to be eligible for this research study:
- Be able to provide informed written consent
- Stated willingness to comply with all study procedures
- Age 18 - 65 years
- Is a daily regular use of nicotine-containing e-cigarette for at least the past 6 months
You likely can't join if
- An individual who meets any of the following criteria will be excluded from participation in this research study:
- Substance use disorder (other than nicotine dependence) (M.I.N.I. SCID) (confirmed with urine drug screen)
- Current regular use of tobacco cigarettes, nicotine replacement therapy or other medications for smoking cessation
- Unstable psychiatric condition
- Recent clinically significant head trauma\
- History of seizures and/or epilepsy\
See the full eligibility criteria
- The participant must meet all of the to be eligible for this research study:
- Be able to provide informed written consent
- Stated willingness to comply with all study procedures
- Age 18 - 65 years
- Is a daily regular use of nicotine-containing e-cigarette for at least the past 6 months
- Is willing to attend daily appointments for tDCS for two consecutive weeks (Monday through Friday)
- Is not interested in or planning to quit vaping in the next 30 days.
- An individual who meets any of the following criteria will be excluded from participation in this research study:
- Substance use disorder (other than nicotine dependence) (M.I.N.I. SCID) (confirmed with urine drug screen)
- Current regular use of tobacco cigarettes, nicotine replacement therapy or other medications for smoking cessation
- Unstable psychiatric condition
- Recent clinically significant head trauma\
- History of seizures and/or epilepsy\
- Pacemakers or implanted electrical devices such as cochlear implants\
- Metal embedded in the skull\
- Skin lesions, open wounds, bruising, or similar injuries on the scalp\
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.